Literature DB >> 29294000

Familial paroxysmal kinesigenic dyskinesia is associated with mutations in the KCNA1 gene.

Xiao-Meng Yin1, Jing-Han Lin2, Li Cao3, Tong-Mei Zhang4,5, Sheng Zeng1, Kai-Lin Zhang1, Wo-Tu Tian3, Zheng-Mao Hu6, Nan Li1,7, Jun-Ling Wang1,6,7, Ji-Feng Guo1,6,8,7, Ruo-Xi Wang6,9, Kun Xia6, Zhuo-Hua Zhang6,9,10, Fei Yin11,12, Jing Peng11,12, Wei-Ping Liao13, Yong-Hong Yi13, Jing-Yu Liu14, Zhi-Xian Yang15, Zhong Chen16,17, Xiao Mao1, Xin-Xiang Yan1, Hong Jiang1,6,8,7, Lu Shen1,6,8,7, Sheng-Di Chen3, Li-Ming Zhang2, Bei-Sha Tang1,6,8,7,18,19.   

Abstract

Paroxysmal kinesigenic dyskinesia (PKD) is a heterogeneous movement disorder characterized by recurrent dyskinesia attacks triggered by sudden movement. PRRT2 has been identified as the first causative gene of PKD. However, it is only responsible for approximately half of affected individuals, indicating that other loci are most likely involved in the etiology of this disorder. To explore the underlying causative gene of PRRT2-negative PKD, we used a combination strategy including linkage analysis, whole-exome sequencing and copy number variations analysis to detect the genetic variants within a family with PKD. We identified a linkage locus on chromosome 12 (12p13.32-12p12.3) and detected a novel heterozygous mutation c.956 T>G (p.319 L>R) in the potassium voltage-gated channel subfamily A member 1, KCNA1. Whole-exome sequencing in another 58 Chinese patients with PKD who lacked mutations in PRRT2 revealed another novel mutation in the KCNA1 gene [c.765 C>A (p.255 N>K)] within another family. Biochemical analysis revealed that the L319R mutant accelerated protein degradation via the proteasome pathway and disrupted membrane expression of the Kv1.1 channel. Electrophysiological examinations in transfected HEK293 cells showed that both the L319R and N255K mutants resulted in reduced potassium currents and respective altered gating properties, with a dominant negative effect on the Kv1.1 wild-type channel. Our study suggests that these mutations in KCNA1 cause the Kv1.1 channel dysfunction, which leads to familial PKD. The current study further extended the genotypic spectrum of this disorder, indicating that Kv1.1 channel dysfunction maybe one of the underlying defects in PKD.
© The Author(s) 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29294000     DOI: 10.1093/hmg/ddx430

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  15 in total

Review 1.  Genetic Dystonias: Update on Classification and New Genetic Discoveries.

Authors:  Ignacio Juan Keller Sarmiento; Niccolò Emanuele Mencacci
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-09       Impact factor: 5.081

2.  Kinesigenic Triggers in Episodic Ataxia Type 1.

Authors:  Claudio M de Gusmao; Lucas Rogerio Garcia; Aaron Jesuthasan; Meaghan Muir; Alex Paciorkowski; Jonathan W Mink; Laura Silveira-Moriyama
Journal:  Mov Disord Clin Pract       Date:  2020-07-19

Review 3.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

Review 4.  Genetic updates on paroxysmal dyskinesias.

Authors:  James Y Liao; Philippe A Salles; Umar A Shuaib; Hubert H Fernandez
Journal:  J Neural Transm (Vienna)       Date:  2021-04-30       Impact factor: 3.575

5.  Interictal Headache, Pseudodystonia, and Persistent Ataxia in Episodic Ataxia Type 1 Due to a Novel KCNA1 Gene Mutation.

Authors:  Shakya Bhattacharjee; Anu Deenadayalu; Vijayashankar Paramanandam
Journal:  Mov Disord Clin Pract       Date:  2021-12-06

6.  Genetics of Paroxysmal Dyskinesia: Novel Variants Corroborate the Role of KCNA1 in Paroxysmal Dyskinesia and Highlight the Diverse Phenotypic Spectrum of KCNA1- and SLC2A1-Related Disorders.

Authors:  Josua Kegele; Johanna Krüger; Mahmoud Koko; Lara Lange; Ana Victoria Marco Hernandez; Francisco Martinez; Alexander Münchau; Holger Lerche; Stephan Lauxmann
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

Review 7.  Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

Authors:  Kelsey Paulhus; Lauren Ammerman; Edward Glasscock
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

8.  Silencing of KCNA1 suppresses the cervical cancer development via mitochondria damage.

Authors:  Li Liu; Yumei Chen; Qingyuan Zhang; Changzhong Li
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

Review 9.  Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.

Authors:  Maria Cristina D'Adamo; Antonella Liantonio; Jean-Francois Rolland; Mauro Pessia; Paola Imbrici
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

10.  Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia.

Authors:  Antonio Castellano; Aurora Pujol; Edgard Verdura; Carme Fons; Agatha Schlüter; Montserrat Ruiz; Stéphane Fourcade; Carlos Casasnovas
Journal:  J Med Genet       Date:  2019-10-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.